Page last updated: 2024-10-31

ethylmaleimide and Medulloblastoma

ethylmaleimide has been researched along with Medulloblastoma in 1 studies

Ethylmaleimide: A sulfhydryl reagent that is widely used in experimental biochemical studies.

Medulloblastoma: A malignant neoplasm that may be classified either as a glioma or as a primitive neuroectodermal tumor of childhood (see NEUROECTODERMAL TUMOR, PRIMITIVE). The tumor occurs most frequently in the first decade of life with the most typical location being the cerebellar vermis. Histologic features include a high degree of cellularity, frequent mitotic figures, and a tendency for the cells to organize into sheets or form rosettes. Medulloblastoma have a high propensity to spread throughout the craniospinal intradural axis. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2060-1)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lukas, RJ1

Other Studies

1 other study available for ethylmaleimide and Medulloblastoma

ArticleYear
Characterization of curaremimetic neurotoxin binding sites on membrane fractions derived from the human medulloblastoma clonal line, TE671.
    Journal of neurochemistry, 1986, Volume: 46, Issue:6

    Topics: Acetylcholine; Binding Sites; Binding, Competitive; Bungarotoxins; Cell Line; Clone Cells; Curare; D

1986